Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
EBS | US
0.16
1.74%
Healthcare
Biotechnology
30/06/2024
04/10/2024
9.35
9.04
9.57
8.86
Emergent BioSolutions Inc. a life sciences company focuses on the provision of preparedness and response solutions that address accidental deliberate and naturally occurring public health threats (PHTs) in the United States. Its products address PHTs which include chemical biological radiological nuclear and explosives; emerging infectious diseases; travel health; public health crises; and acute emergency and community care. The company offers ACAM2000 a smallpox vaccine; Anthrasil to for inhalational anthrax; Botulism Antitoxin Heptavalent to treat botulinum disease; BioThrax an anthrax vaccine; Ebanga a monoclonal antibody to treat infection caused by Zaire ebolavirus; raxibacumab injection for the treatment of inhalational anthrax; reactive skin decontamination lotion kits; TEMBEXA for the treatment of human smallpox disease; Trobigard an auto-injector atropine sulfate and obidoxime chloride auto-injector for the emergency treatment of known or suspected exposure to nerve agents; and vaccinia immune globulin intravenous that addresses complications from smallpox vaccine. It also provides NARCAN a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif an oral vaccine for typhoid fever; and Vaxchora a single-dose oral vaccine to treat cholera. In addition the company is developing AV7909 an anthrax vaccine; CGRD-001 a pralidoxime chloride/atropine auto-injector; CHIKV VLP a chikungunya virus VLP vaccine; EBS-LASV; EGRD-001 a diazepam auto-injector; SIAN an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu a universal influenza vaccine. Further it provides contract development and manufacturing services comprising drug substance and product manufacturing and packaging as well as technology transfer process and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg Maryland.
View LessPositive Momentum
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
High Debt to Asset (> 0.45)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
142.2%1 month
105.1%3 months
182.4%6 months
179.0%-
7.94
1.03
2.27
0.58
6.87
1.11
1.55
-79.30M
494.68M
494.68M
-
-62.47
2.20
-24.60
-87.44
1.27
10.32
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.88
Range1M
3.88
Range3M
9.85
Rel. volume
0.75
Price X volume
15.28M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Revance Therapeutics Inc | RVNC | Biotechnology | 5.22 | 543.82M | 0.58% | n/a | -378.95% |
UroGen Pharma Ltd | URGN | Biotechnology | 12.7 | 534.85M | 0.95% | n/a | 326.69% |
4D Molecular Therapeutics Inc | FDMT | Biotechnology | 9.97 | 518.14M | -2.92% | n/a | 2.32% |
Third Harmonic Bio Inc. | THRD | Biotechnology | 12.52 | 514.54M | -0.71% | n/a | 1.40% |
SIGA Technologies Inc | SIGA | Biotechnology | 6.98 | 498.16M | 0.87% | 5.95 | 0.97% |
CorMedix Inc | CRMD | Biotechnology | 8.9 | 497.15M | 7.62% | n/a | 1.29% |
KalVista Pharmaceuticals Inc | KALV | Biotechnology | 11.36 | 490.93M | -4.05% | n/a | 3.62% |
PureTech Health plc | PRTC | Biotechnology | 20.33 | 486.74M | 5.39% | n/a | 29.73% |
REGENXBIO Inc | RGNX | Biotechnology | 9.72 | 480.39M | -2.02% | n/a | 45.57% |
Anavex Life Sciences Corp | AVXL | Biotechnology | 5.595 | 474.43M | -1.06% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.64 | 83.40M | -1.93% | n/a | 58.43% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 6.87 | 0.76 | Expensive |
Ent. to Revenue | 1.11 | 3,674.48 | Cheaper |
PE Ratio | - | 38.01 | - |
Price to Book | 1.03 | 14.10 | Cheaper |
Dividend Yield | - | 2.22 | - |
Std. Deviation (3M) | 182.35 | 74.67 | Riskier |
Debt to Equity | 2.27 | -1.82 | Expensive |
Debt to Assets | 0.58 | 0.26 | Expensive |
Market Cap | 494.68M | 3.73B | Emerging |